News Headlines Article

CMS reverses position on coverage for tumor scans
Modern Healthcare

Physicians, patients and medical imaging companies talked the CMS out of virtually ending Medicare payment for post-treatment positron emission tomography scans for solid tumors. The agency reversed its March proposal to end payment for such post-treatment scans for prostate cancer and limit coverage to one scan for other cancers. Instead, Medicare will cover three scans ordered to help guide subsequent anti-tumor treatment. The CMS will allow local Medicare Administrative Contractors, or MACs, to determine coverage for additional scans.